These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30445489)

  • 1. Predictors of mid-term outcomes in patients undergoing implantation of a ventricular assist device directly after extracorporeal life support.
    Tsyganenko D; Gromann TW; Schoenrath F; Mueller M; Mulzer J; Starck C; Krabatsch T; Stein J; Falk V; Potapov E
    Eur J Cardiothorac Surg; 2019 Apr; 55(4):773-779. PubMed ID: 30445489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
    Noly PE; Kirsch M; Quessard A; Leger P; Pavie A; Amour J; Leprince P
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal Life Support Bridge to Ventricular Assist Device: The Double Bridge Strategy.
    Marasco SF; Lo C; Murphy D; Summerhayes R; Quayle M; Zimmet A; Bailey M
    Artif Organs; 2016 Jan; 40(1):100-6. PubMed ID: 25980985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal life support prior to left ventricular assist device implantation leads to improvement of the patients INTERMACS levels and outcome.
    Schibilsky D; Haller C; Lange B; Schibilsky B; Haeberle H; Seizer P; Gawaz M; Rosenberger P; Walker T; Schlensak C
    PLoS One; 2017; 12(3):e0174262. PubMed ID: 28358849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal membrane oxygenation as perioperative right ventricular support in patients with biventricular failure undergoing left ventricular assist device implantation.
    Scherer M; Sirat AS; Moritz A; Martens S
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):939-44; discussion 944. PubMed ID: 21071240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of percutaneous veno-arterial extracorporeal membrane oxygenation as bridge to left ventricular assist device.
    Toda K; Fujita T; Seguchi O; Yanase M; Nakatani T
    J Artif Organs; 2018 Mar; 21(1):39-45. PubMed ID: 28871334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of venopulmonary arterial extracorporeal life support as temporary right ventricular support after left ventricular assist implantation.
    Shehab S; Rao S; Macdonald P; Newton PJ; Spratt P; Jansz P; Hayward CS
    J Thorac Cardiovasc Surg; 2018 Dec; 156(6):2143-2152. PubMed ID: 30025607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team.
    Guenther S; Theiss HD; Fischer M; Sattler S; Peterss S; Born F; Pichlmaier M; Massberg S; Hagl C; Khaladj N
    Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):283-91. PubMed ID: 24336784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impella 5.0 therapy as a bridge-to-decision option for patients on extracorporeal life support with unclear neurological outcomes.
    Bernhardt AM; Zipfel S; Reiter B; Hakmi S; Castro L; Söffker G; Kluge S; Lubos E; Rybczinski M; Grahn H; Schrage B; Becher PM; Barten MJ; Westermann D; Blankenberg S; Reichenspurner H
    Eur J Cardiothorac Surg; 2019 Dec; 56(6):1031-1036. PubMed ID: 31038672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central Extracorporeal Life Support With Left Ventricular Decompression to Berlin Heart Excor: A Reliable "Bridge to Bridge" Strategy in Crash and Burn Patients.
    Weymann A; Farag M; Sabashnikov A; Fatullayev J; Zeriouh M; Schmack B; Arif R; Müller F; Alt C; Raake P; Prakash Patil N; Popov AF; Rüdiger Simon A; Karck M; Ruhparwar A;
    Artif Organs; 2017 Jun; 41(6):519-528. PubMed ID: 27862040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of extracorporeal membrane oxygenation in patients with therapy refractory cardiogenic shock as a bridge to implantable left ventricular assist device and perioperative right heart support.
    Scherer M; Moritz A; Martens S
    J Artif Organs; 2009; 12(3):160-5. PubMed ID: 19894089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Perioperative Right Ventricular Support Prevent Postoperative Right Heart Failure in Patients With Biventricular Dysfunction Undergoing Left Ventricular Assist Device Implantation?
    Deschka H; Holthaus AJ; Sindermann JR; Welp H; Schlarb D; Monsefi N; Martens S; Scherer M
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):619-26. PubMed ID: 27321789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS Level I patients receiving a permanent ventricular assist device.
    Riebandt J; Haberl T; Mahr S; Laufer G; Rajek A; Steinlechner B; Schima H; Zimpfer D
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):486-92; discussion 492. PubMed ID: 24648428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access.
    Schibilsky D; Lausberg H; Haller C; Lenglinger M; Woernle B; Haeberle H; Rosenberger P; Walker T; Schlensak C
    Artif Organs; 2015 Aug; 39(8):660-3. PubMed ID: 26147682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective implantation of durable left ventricular assist devices as primary therapy for refractory cardiogenic shock.
    Pawale A; Schwartz Y; Itagaki S; Pinney S; Adams DH; Anyanwu AC
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1059-1068. PubMed ID: 29274911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impella 5.0 as a Second-Line Mechanical Circulatory Support Strategy After Extracorporeal Life Support.
    Schibilsky D; Kruger T; Lausberg HF; Eisenlohr C; Haller C; Nemeth A; Schibilsky B; Haeberle H; Rosenberger P; Walker T; Schlensak C
    Artif Organs; 2016 Sep; 40(9):909-16. PubMed ID: 27645397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Bleeding During Right Ventricular Support After Left Ventricular Assist Device Implantation.
    Welp H; Sindermann JR; Deschka H; Martens S; Scherer M
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):627-31. PubMed ID: 26460277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute lung injury after mechanical circulatory support implantation in patients on extracorporeal life support: an unrecognized problem.
    Boulate D; Luyt CE; Pozzi M; Niculescu M; Combes A; Leprince P; Kirsch M
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):544-9; discussion 549-50. PubMed ID: 23477925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival predictors in ventricular assist device patients with prior extracorporeal life support: selecting appropriate candidates.
    Maxhera B; Albert A; Ansari E; Godehardt E; Lichtenberg A; Saeed D
    Artif Organs; 2014 Sep; 38(9):727-32. PubMed ID: 25234756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.